Neuronoff, Inc.
PrivateLast Round
Early Funding
Oct 8, 2025
Total Funding Raised
$11.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuronoff, Inc. is a medical devices company developing an injectable electrode platform for minimally invasive neuromodulation to treat chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuronoff, Inc. Comparables
Compare Neuronoff, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPR Therapeutics | 76% | |
| Curonix | 74% | |
| Uro Medical Corporation | 71% |
Neuronoff, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 8, 2025 | ||||
| Grant | Jan 30, 2025 | ||||
| Grant | Aug 1, 2023 | ||||
| Grant | Oct 31, 2019 |
Neuronoff, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| United States Department of Defense | Grant |
| U.S. Department of Defense | Grant |
| NIH RADx | Grant |
| U.S. Department of War | Grant |
| MedTech Angels | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 126% MoM, from 1.3K to 3K.
- Mar 16, 2026
Announced successful chronic large animal demonstration of IPG-compatible Injectrode platform.
Neuronoff, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neuronoff, Inc.'s valuation, stock price, and market status.
Is Neuronoff, Inc. a public or private company?
Neuronoff, Inc. is a private company.
What is the current stock price of Neuronoff, Inc.?
Neuronoff, Inc. is a private company, so its shares have no public market price. Caplight tracks Neuronoff, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuronoff, Inc. worth (valuation)?
Valuation information for Neuronoff, Inc. is not publicly available.
Can I buy Neuronoff, Inc. stock?
Neuronoff, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuronoff, Inc.'s last funding round?
Neuronoff, Inc.'s most recent funding round was Early Funding on October 8, 2025.
Who are the main investors in Neuronoff, Inc.?
Key investors in Neuronoff, Inc. include U.S. Department of Health and Human Services, United States Department of Defense, U.S. Department of Defense, NIH RADx, U.S. Department of War.
Will Neuronoff, Inc. IPO soon?
No public IPO plans have been announced for Neuronoff, Inc..
How can I track Neuronoff, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Neuronoff, Inc.'s shares on secondary markets.